On November 2, 2016, OWC Pharmaceutical Research Corp. accepted the resignation of Dr. Asaf Toker as Chief Science Officer, a position to which he was appointed in October 2015. Effective on November 2, 2016, and in connection with the acceptance of Dr. Toker's resignation, the Registrant immediately appointed Dr. Yehuda Baruch, as Chief Science Officer. Prior to his appointment, Dr. Baruch served as Director of Research and Regulatory Affairs of the Registrant's wholly-owned Israeli subsidiary, One World Cannabis Ltd. since January 2015. Prior to joining the Registrant, Dr. Baruch served as Head of the Israeli Ministry of Health's Medical Marijuana Program from 2003 through 2013, directing its efforts on regulation, chaired the indication committee, secured Helsinki Approvals for medical research, and managed regulation of patient licensing and dosage. Dr. Baruch has extensive experience in researching medical cannabis, most notably for its effect on PTSD. From 2004 until 2014, Dr. Baruch also served as CEO of Abarbanel Mental Health Center in Bat Yam, Israel, prior to which, he was the director of Israel's Ministry of Health medical management division, and director general of Be'er Yakov Mental Health Center.